{"subsection_name": null, "pub_date": "2011-10-03T00:00:00Z", "byline": {"original": "By ANDREW POLLACK", "contributor": "", "person": [{"lastname": "POLLACK", "organization": "", "rank": 1, "role": "reported", "firstname": "Andrew"}]}, "abstract": null, "word_count": "624", "print_page": "3", "news_desk": "Business", "snippet": "After doubts about the drug\u2019s efficacy, the Food and Drug Administration is considering whether to rescind approval of it for the treatment of breast cancer.", "multimedia": [], "source": "The New York Times", "blog": [], "keywords": [{"name": "subject", "is_major": "N", "value": "Health Insurance and Managed Care", "rank": "1"}, {"name": "subject", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "rank": "2"}, {"name": "subject", "is_major": "N", "value": "Breast Cancer", "rank": "3"}, {"name": "subject", "is_major": "N", "value": "Medicine and Health", "rank": "4"}, {"name": "subject", "is_major": "N", "value": "Avastin (Drug)", "rank": "5"}, {"name": "organizations", "is_major": "N", "value": "Genentech Inc", "rank": "6"}, {"name": "organizations", "is_major": "N", "value": "Blue Shield of California", "rank": "7"}], "type_of_material": "News", "lead_paragraph": "After doubts about the drug\u2019s efficacy, the Food and Drug Administration is considering whether to rescind approval of it for the treatment of breast cancer.", "web_url": "http://www.nytimes.com/2011/10/03/business/blue-shield-of-california-wont-cover-breast-cancer-drug.html", "section_name": "Business Day", "headline": {"main": "Blue Shield of California Won\u2019t Cover Breast Cancer Drug", "print_headline": "Blue Shield of California Won\u2019t Cover Breast Cancer Drug", "seo": "Blue Shield of California Won\u2019t Cover Breast Cancer Drug"}, "slideshow_credits": null, "_id": "5401acaa38f0d841b2f39f7f", "document_type": "article"}